Intelligence · Clinical Pipeline
Tonix Pharmaceuticals Holding Pipeline
All ClinicalTrials.gov programs at Tonix Pharmaceuticals Holding — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
Tonix Pharmaceuticals Holding has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Cyclobenzaprine HCl
Tonix Pharmaceuticals Holding
Acute Stress Reaction
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection
1 trial -
TNX-1300
Tonix Pharmaceuticals Holding
Cocaine Intoxication
1 trial -
TNX-1500
Tonix Pharmaceuticals Holding
Kidney Transplant
1 trial -
TNX-1900
Tonix Pharmaceuticals Holding
Chronic Migraine
1 trial -
TNX-201
Tonix Pharmaceuticals Holding
Tension-Type Headache
1 trial -
TNX-601 ER
Tonix Pharmaceuticals Holding
Depression
1 trial
Frequently asked questions
How many pipeline programs does Tonix Pharmaceuticals Holding have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs